Literature DB >> 14622134

Androgens modulate beta-amyloid levels in male rat brain.

M Ramsden1, A C Nyborg, M P Murphy, L Chang, F Z Stanczyk, T E Golde, C J Pike.   

Abstract

As a normal consequence of aging, men experience a significant decline in androgen levels. Although the neural consequences of age-related androgen depletion remain unclear, recent evidence suggests a link between low androgen levels and the development of Alzheimer's disease (AD). Here, we test the hypothesis that androgens act as endogenous modulators of beta-amyloid protein (Abeta) levels. To investigate this possibility, brain and plasma levels of Abeta were measured in male rats with varying hormonal conditions. Depletion of endogenous sex steroid hormones via gonadectomy (GDX) resulted in increased brain levels of Abeta in comparison to gonadally intact male rats. This GDX-induced increase in Abeta levels was reversed by DHT supplementation, demonstrating a functional role for androgens in modulating brain levels of Abeta. These findings suggest that age-related androgen depletion may result in accumulation of Abeta in the male brain and thereby act as a risk factor for the development of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622134     DOI: 10.1046/j.1471-4159.2003.02114.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells.

Authors:  Wei Li; Akhilesh K Pandey; Xiangling Yin; Jau-Jiin Chen; Douglas M Stocco; Paula Grammas; Xingjia Wang
Journal:  J Nutr Biochem       Date:  2011-03       Impact factor: 6.048

Review 2.  Cognitive changes associated with ADT: a review of the literature.

Authors:  Rhoda J Jamadar; Mary J Winters; Pauline M Maki
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

3.  Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

Authors:  Carrie McAllister; Jiangang Long; Adrienne Bowers; Aaron Walker; Philip Cao; Shin-Ichiro Honda; Nobuhiro Harada; Matthias Staufenbiel; Yong Shen; Rena Li
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Géraldine H Petit; Gunnar K Gouras; Patrik Brundin; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-09-25       Impact factor: 4.418

Review 5.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Authors:  Emily R Rosario; Lilly Chang; Elizabeth H Head; Frank Z Stanczyk; Christian J Pike
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

Review 7.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

8.  Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells.

Authors:  Shaletha Holmes; Babak Abbassi; Chang Su; Meharvan Singh; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2013-08-19       Impact factor: 4.736

9.  Gene expression profiling in the hippocampus of orchidectomized rats.

Authors:  Telma Quintela; Helena Marcelino; Isabel Gonçalves; Filipa M Patriarca; Cecília R A Santos
Journal:  J Mol Neurosci       Date:  2014-04-24       Impact factor: 3.444

Review 10.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.